[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][N][C][=Branch1][C][=O][C][C][=Branch1][C][=O][N][Branch1][=C][C][=C][Ring1][=Branch2][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][Cl][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is expected to have a better side-effect profile compared to older 1,4-benzodiazepines. It has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984. The oral preparation was FDA approved on October 21, 2011. An oral suspension is expected to be available in 2013."}]